D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Community Health Systems
CYH
$420M
| $842K | ﹤0.01% |
225,917
+199,287
| +748% | +$743K |
|
|
KG
1877
Kestrel Group, Ltd.
KG
$203M
| $838K | ﹤0.01% |
56,421
+44,309
| +366% | +$658K |
|
1878
Pool Corp
POOL
$12.3B
| $837K | ﹤0.01% |
5,072
-14,104
| -74% | -$2.33M |
|
1879
Turning Point Brands
TPB
$1.81B
| $837K | ﹤0.01% |
18,163
+4,469
| +33% | +$206K |
|
1880
Barings BDC
BBDC
$995M
| $826K | ﹤0.01% |
84,210
+70,868
| +531% | +$695K |
|
1881
Clear Channel Outdoor Holdings
CCO
$661M
| $826K | ﹤0.01% |
154,330
+3,168
| +2% | +$17K |
|
1882
Acacia Research
ACTG
$314M
| $821K | ﹤0.01% |
251,980
+71,640
| +40% | +$233K |
|
1883
Enterprise Financial Services Corp
EFSC
$2.27B
| $815K | ﹤0.01% |
20,001
-26,877
| -57% | -$1.1M |
|
1884
Main Street Capital
MAIN
$6.01B
| $814K | ﹤0.01% |
+21,884
| New | +$814K |
|
1885
Mizuho Financial
MFG
$82.4B
| $813K | ﹤0.01% |
265,774
-182,403
| -41% | -$558K |
|
1886
Scansource
SCSC
$994M
| $810K | ﹤0.01% |
+22,600
| New | +$810K |
|
1887
TransAlta
TAC
$3.75B
| $810K | ﹤0.01% |
110,200
-19,100
| -15% | -$140K |
|
1888
Atlanta Braves Holdings Series B
BATRK
$2.66B
| $809K | ﹤0.01% |
29,126
-6,135
| -17% | -$170K |
|
1889
TransDigm Group
TDG
$72.9B
| $809K | ﹤0.01% |
1,782
+782
| +78% | +$355K |
|
|
BMTC
1890
DELISTED
Bryn Mawr Bank Corp
BMTC
| $807K | ﹤0.01% |
22,349
-14,985
| -40% | -$541K |
|
1891
Domino's
DPZ
$15.5B
| $805K | ﹤0.01% |
3,119
-4,269
| -58% | -$1.1M |
|
1892
Exelixis
EXEL
$10.5B
| $804K | ﹤0.01% |
33,794
-83,184
| -71% | -$1.98M |
|
|
ENZ
1893
DELISTED
Enzo Biochem, Inc.
ENZ
| $802K | ﹤0.01% |
293,953
+55,588
| +23% | +$152K |
|
|
FBM
1894
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $795K | ﹤0.01% |
80,840
+15,698
| +24% | +$154K |
|
1895
TriplePoint Venture Growth BDC
TPVG
$271M
| $794K | ﹤0.01% |
+57,736
| New | +$794K |
|
|
CZZ
1896
DELISTED
Cosan Limited
CZZ
| $794K | ﹤0.01% |
68,475
-25,901
| -27% | -$300K |
|
1897
Silicom
SILC
$104M
| $791K | ﹤0.01% |
20,676
+11,088
| +116% | +$424K |
|
1898
Theravance Biopharma
TBPH
$690M
| $791K | ﹤0.01% |
34,871
-40,163
| -54% | -$911K |
|
|
MSGN
1899
DELISTED
MSG Networks Inc.
MSGN
| $791K | ﹤0.01% |
36,353
+2,565
| +8% | +$55.8K |
|
1900
FTI Consulting
FCN
$5.4B
| $784K | ﹤0.01% |
10,206
-11,316
| -53% | -$869K |
|